Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Arterial hypertension (AHT) is a major cardio-reno-vascular risk factor (CVRF) that can lead to kidney injury. It is known that AHT as well as diabetes or smoking can lead to glomerular hyperfiltration and hypertrophy, and later to nephron loss and chronic kidney disease (CKD). In our study, we analysed whether AHT is associated with sex/age specific changes in kidney size.
We included 1916 participants (983 females) between 21 and 81 years without kidney disease for measurement of left and right renal volume (RV) using magnetic resonance imaging from the Study of Health in Pomerania (SHIP-TREND-0). We defined two subgroups of AHT, namely AHT1: systolic BP > 140 mmHg or diastolic BP > 90 mmHg or presence of AHT in the standardised interview or intake of antihypertensive medication, AHT2: intake of antihypertensive medication). We analysed AHT1 and AHT2 separately. Linear regression models adjusted for confounding factors were performed for both subgroups of AHT and kidney size.
AHT1 was associated with a higher RV in males, particularly for the right RV (β = 6.18; 95 % CI 2.02; 10.32; p < 0.05). In contrast, we found no significant association of AHT1 with RV in females. AHT2 was only associated with the right RV in males (β = 4.71; 95 % CI 0.25; 9.16; p < 0.05). Both AHT1 and AHT2 were significant associated with RV up to an age of around 55 years. Age-dependent associations were stronger in males than in females for nearly all ages.
Associations of both AHT1 and AHT2 with RV were stronger in males than in females. The accumulation of CVRF in middle-aged males possibly explained by gendered behaviour may account for the sex differences seen for RV in participants with AHT in our population.
